A PHASE-I TRIAL OF TOP-53 BY HYBRID DOSE-ESCALATION STRATEGY BASED ONPGDE AND CRM

Authors
SASAKI Y OHASHI Y MINAMI H OHTSU T FUJII M IGARASHI T WATANABE Y ONOZAWA Y KODAMA K ITO K ISHIZUKA N BANDO T TSUDA M YAMAGUCHI Y SUZUKI T
Citation
Y. Sasaki et al., A PHASE-I TRIAL OF TOP-53 BY HYBRID DOSE-ESCALATION STRATEGY BASED ONPGDE AND CRM, Annals of oncology, 9, 1998, pp. 242-242
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
242 - 242
Database
ISI
SICI code
0923-7534(1998)9:<242:APTOTB>2.0.ZU;2-4